应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
IMDX Insight Molecular Diagnostics Inc.
交易中 12-16 15:37:54 EST
5.06
+0.04
+0.80%
最高
5.06
最低
5.00
成交量
7,992
今开
5.02
昨收
5.02
日振幅
1.20%
总市值
1.45亿
流通市值
3,934万
总股本
2,866万
成交额
4.02万
换手率
0.10%
流通股本
777.55万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Insight Molecular Diagnostics Inc.盘中异动 下午盘股价大跌5.06%
市场透视 · 11-20
Insight Molecular Diagnostics Inc.盘中异动 下午盘股价大跌5.06%
Insight Molecular Diagnostics Inc.盘中异动 早盘股价大跌5.27%
市场透视 · 11-17
Insight Molecular Diagnostics Inc.盘中异动 早盘股价大跌5.27%
Insight Molecular Diagnostics Inc.报告肾移植患者通过新疗法和Graftassure监测实现"免疫重置"
美股速递 · 10-06
Insight Molecular Diagnostics Inc.报告肾移植患者通过新疗法和Graftassure监测实现"免疫重置"
Oncocyte Corporation盘中异动 早盘股价大涨8.30%
市场透视 · 06-16
Oncocyte Corporation盘中异动 早盘股价大涨8.30%
加载更多
公司概况
公司名称:
Insight Molecular Diagnostics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Insight Molecular Diagnostics Inc.于2009年在加利福尼亚州注册成立,是Bio Time的一家拥有多数股权的子公司。该公司是一家精准诊断公司,专注于开发和商业化三个领域的专有测试:VitaGraft是一种基于血液的实体器官移植监测测试,DetermaIO是一种评估肿瘤微环境以预测对免疫疗法的反应的基因表达测试,DetermaCNI是一种基于血液的监测工具,用于监测癌症患者的治疗效果。该公司正在继续开发DetermaIO,这是一种具有前景数据的测试,支持其帮助识别可能对检查点抑制剂药物产生反应的患者的潜力。这类新药可调节免疫反应,在包括非小细胞肺癌(NSCLC)、三阴性乳腺癌(TNBC)在内的多种实体瘤类型中显示活性。
发行价格:
--
{"stockData":{"symbol":"IMDX","market":"US","secType":"STK","nameCN":"Insight Molecular Diagnostics Inc.","latestPrice":5.06,"timestamp":1765917403113,"preClose":5.02,"halted":0,"volume":7992,"delay":0,"floatShares":7775507,"shares":28664437,"eps":-2.267159,"marketStatus":"交易中","change":0.04,"latestTime":"12-16 15:37:54 EST","open":5.015,"high":5.06,"low":5,"amount":40179.076704,"amplitude":0.011952,"askPrice":5.08,"askSize":8,"bidPrice":5.05,"bidSize":116,"shortable":3,"etf":0,"ttmEps":-2.267159,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765918800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":5.02,"postHourTrading":{"tag":"盘后","latestPrice":5.02,"preClose":5.02,"latestTime":"16:10 EST","volume":621,"amount":3117.42,"timestamp":1765833005083},"volumeRatio":0.369511,"impliedVol":3.3034,"impliedVolPercentile":0.9583},"requestUrl":"/m/hq/s/IMDX","defaultTab":"news","newsList":[{"id":"2585600156","title":"Insight Molecular Diagnostics Inc.盘中异动 下午盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585600156","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585600156?lang=zh_cn&edition=full","pubTime":"2025-11-20 03:38","pubTimestamp":1763581118,"startTime":"0","endTime":"0","summary":"北京时间2025年11月20日03时38分,Insight Molecular Diagnostics Inc.股票出现异动,股价急速跳水5.06%。截至发稿,该股报6.01美元/股,成交量3.4962万股,换手率0.12%,振幅7.74%。Insight Molecular Diagnostics Inc.股票所在的生命科学行业中,整体跌幅为0.38%。Insight Molecular Diagnostics Inc.公司简介:Insight Molecular Diagnostics Inc是一家开创性的诊断技术公司,其使命是使新型分子诊断测试的普及化,以改善患者治疗效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120033839950f0b5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120033839950f0b5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAQU","IMDX","BK4139"],"gpt_icon":0},{"id":"2584765608","title":"Insight Molecular Diagnostics Inc.盘中异动 早盘股价大跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584765608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584765608?lang=zh_cn&edition=full","pubTime":"2025-11-17 22:48","pubTimestamp":1763390907,"startTime":"0","endTime":"0","summary":"北京时间2025年11月17日22时48分,Insight Molecular Diagnostics Inc.股票出现异动,股价快速跳水5.27%。截至发稿,该股报7.01美元/股,成交量1.9038万股,换手率0.07%,振幅6.91%。Insight Molecular Diagnostics Inc.股票所在的生命科学行业中,整体跌幅为0.46%。Insight Molecular Diagnostics Inc.公司简介:Insight Molecular Diagnostics Inc是一家开创性的诊断技术公司,其使命是使新型分子诊断测试的普及化,以改善患者治疗效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117224827976f1846&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117224827976f1846&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAQU","IMDX","BK4139"],"gpt_icon":0},{"id":"1182150281","title":"Insight Molecular Diagnostics Inc.报告肾移植患者通过新疗法和Graftassure监测实现\"免疫重置\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1182150281","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182150281?lang=zh_cn&edition=full","pubTime":"2025-10-06 19:16","pubTimestamp":1759749375,"startTime":"0","endTime":"0","summary":"Insight Molecular Diagnostics Inc.宣布,一名肾移植患者通过该公司的创新疗法结合Graftassure监测技术,成功实现了\"免疫重置\"。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMDX","BK4139"],"gpt_icon":0},{"id":"2543605433","title":"Oncocyte Corporation盘中异动 早盘股价大涨8.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543605433","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543605433?lang=zh_cn&edition=full","pubTime":"2025-06-16 22:18","pubTimestamp":1750083487,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日22时18分,Oncocyte Corporation股票出现异动,股价大幅拉升8.30%。截至发稿,该股报2.87美元/股,成交量1430股,换手率0.01%,振幅1.70%。Oncocyte Corporation股票所在的生命科学行业中,整体涨幅为0.78%。其相关个股中,Genedx Holdings Corp C/Wts 22/07/2026 、Personalis, Inc.、Oncocyte Corporation涨幅较大,Applied Dna Sciences, Inc.、Endra Life Sciences Inc.、Mainz Biomed N.V.较为活跃,换手率分别为9.37%、1.19%、0.50%,振幅较大的相关个股有Genedx Holdings Corp C/Wts 22/07/2026 、Personalis, Inc.、Applied Dna Sciences, Inc.,振幅分别为28.91%、9.48%、8.97%。Oncocyte Corporation公司简介:OncoCyte Corp 是一家开创性的诊断技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506162218089781f85c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506162218089781f85c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCX","IMDX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.oncocyte.com","stockEarnings":[{"period":"1week","weight":0.0162},{"period":"1month","weight":-0.3216},{"period":"3month","weight":0.4593},{"period":"6month","weight":0.5886},{"period":"1year","weight":1.1638},{"period":"ytd","weight":1.1092}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.1266},{"period":"ytd","weight":0.1615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Insight Molecular Diagnostics Inc.于2009年在加利福尼亚州注册成立,是Bio Time的一家拥有多数股权的子公司。该公司是一家精准诊断公司,专注于开发和商业化三个领域的专有测试:VitaGraft是一种基于血液的实体器官移植监测测试,DetermaIO是一种评估肿瘤微环境以预测对免疫疗法的反应的基因表达测试,DetermaCNI是一种基于血液的监测工具,用于监测癌症患者的治疗效果。该公司正在继续开发DetermaIO,这是一种具有前景数据的测试,支持其帮助识别可能对检查点抑制剂药物产生反应的患者的潜力。这类新药可调节免疫反应,在包括非小细胞肺癌(NSCLC)、三阴性乳腺癌(TNBC)在内的多种实体瘤类型中显示活性。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.314148},{"month":2,"riseRate":0.2,"avgChangeRate":-0.066709},{"month":3,"riseRate":0.8,"avgChangeRate":0.036833},{"month":4,"riseRate":0.5,"avgChangeRate":-0.026133},{"month":5,"riseRate":0.4,"avgChangeRate":-0.004941},{"month":6,"riseRate":0.3,"avgChangeRate":-0.09229},{"month":7,"riseRate":0.2,"avgChangeRate":-0.117226},{"month":8,"riseRate":0.5,"avgChangeRate":0.0149},{"month":9,"riseRate":0.5,"avgChangeRate":0.06731},{"month":10,"riseRate":0.3,"avgChangeRate":-0.033729},{"month":11,"riseRate":0.5,"avgChangeRate":0.046403},{"month":12,"riseRate":0.3,"avgChangeRate":-0.047773}],"exchange":"NASDAQ","name":"Insight Molecular Diagnostics Inc.","nameEN":"Insight Molecular Diagnostics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Insight Molecular Diagnostics Inc.(IMDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Insight Molecular Diagnostics Inc.(IMDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Insight Molecular Diagnostics Inc.,IMDX,Insight Molecular Diagnostics Inc.股票,Insight Molecular Diagnostics Inc.股票老虎,Insight Molecular Diagnostics Inc.股票老虎国际,Insight Molecular Diagnostics Inc.行情,Insight Molecular Diagnostics Inc.股票行情,Insight Molecular Diagnostics Inc.股价,Insight Molecular Diagnostics Inc.股市,Insight Molecular Diagnostics Inc.股票价格,Insight Molecular Diagnostics Inc.股票交易,Insight Molecular Diagnostics Inc.股票购买,Insight Molecular Diagnostics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Insight Molecular Diagnostics Inc.(IMDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Insight Molecular Diagnostics Inc.(IMDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}